Edition:
United Kingdom

Hologic Inc (HOLX.OQ)

HOLX.OQ on NASDAQ Stock Exchange Global Select Market

43.93USD
5:52pm GMT
Change (% chg)

$0.40 (+0.92%)
Prev Close
$43.53
Open
$43.79
Day's High
$44.19
Day's Low
$43.79
Volume
201,490
Avg. Vol
930,894
52-wk High
$46.80
52-wk Low
$35.78

Chart for

About

Hologic, Inc. is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products with an emphasis on women's health. The Company operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The diagnostics products include Aptima family of assays,... (more)

Overall

Beta: 0.94
Market Cap(Mil.): $10,571.04
Shares Outstanding(Mil.): 280.47
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 168.71 16.44
EPS (TTM): -- -- --
ROI: -- 9.50 10.62
ROE: -- 14.87 14.20

BRIEF-Third Respiratory Assay now FDA cleared on Hologic's new Panther Fusion system

* THIRD RESPIRATORY ASSAY NOW FDA CLEARED ON HOLOGIC'S NEW PANTHER FUSION® SYSTEM

06 Dec 2017

BRIEF-HOLOGIC RECEIVES FDA 510(K) CLEARANCE OF QUANTRA 2.2 BREAST DENSITY ASSESSMENT SOFTWARE

* HOLOGIC RECEIVES FDA 510(K) CLEARANCE OF QUANTRA 2.2 BREAST DENSITY ASSESSMENT SOFTWARE

24 Nov 2017

BRIEF-Hologic announces upcoming put option

* Hologic announces upcoming put option and notice of redemption of 2.00% convertible senior notes due 2043 Source text for Eikon: Further company coverage:

14 Nov 2017

BRIEF-Hologic announces Q4 GAAP earnings per share $0.29

* Hologic announces financial results for fourth quarter of fiscal 2017

08 Nov 2017

BRIEF-Hologic - ‍received 510(k) clearance from FDA for Panther Fusion Paraflu assay​

* Hologic Inc - ‍received 510(k) clearance from FDA for Panther Fusion Paraflu assay​ Source text for Eikon: Further company coverage:

26 Oct 2017

EXCLUSIVE-Siemens mandates three banks for IPO of Healthineers unit -sources

* Stock market float expected in June/July 2018 -sources (Adds valuation, details)

24 Oct 2017

BRIEF-Hologic prices offering of $350 mln 4.375 pct senior notes due 2025

* Hologic announces pricing of offering of $350 million aggregate principal amount of 4.375% senior notes due 2025

04 Oct 2017

BRIEF-Hologic announces offering of $350 mln of senior notes due 2025

* Hologic announces offering of $350 million of senior notes due 2025

04 Oct 2017

BRIEF-Hologic enters into amended and restated five-year secured credit agreement

* Hologic enters into amended and restated five-year secured credit agreement

04 Oct 2017

BRIEF-Hologic receives FDA 510(k) clearance to market SculpSure

* Hologic receives FDA 510(k) clearance to market SculpSure for non-invasive body contouring (lipolysis) of the submental area (under the chin)

27 Sep 2017

Competitors

Earnings vs. Estimates